Jaume Galcerán
Datos Biográficos
| ID | 7802776 |
|---|---|
| NOMBRE | Jaume Galcerán |
| NOMBRES | Jaume |
| APELLIDO | Galcerán |
| FIRMA | GALCERAN J |
| AFILIACIONES | Institut de Recerca Biomèdica Catalunya Sud |
| ORCID | 0000-0002-1584-7293 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 14 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 14 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2011 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
A European collaborative initiative to systematically map cancer risk by migration background
BACKGROUND: The World Health Organization (WHO) Action Plan for Refugee and Migrant Health highlights the need for strengthened migration health governance and data-informed policies. A major barrier in Europe has been the lack of systematically collected and comparable cancer data stratified by migration background. METHODS: This study assesses the availability of routine data to map and examines differences of cancer risk among those with a mig…
Mejorando El Programa De Cribado Del Cáncer Colorrectal Con Una Firma Bacteriana en El Protocolo
Estudio Poblacional De La Incidencia Y Supervivencia Del Carcinoma Epidermoide Cutáneo en España
Is Cancer Increasing in Young Adults in Spain? Incidence Trends for the Period 1993-2018
Registration of Urothelial Tumours in Cancer Registries
Due to the differences in the definition, criteria of inclusion and coding of urothelial tumours (UTs), data of different cancer registries (CRs) are not comparable. The aim of this work is to study current practices of registration of UT in the European CR of the GRELL countries in order to propose new registration rules to correctly describe incidence and survival of progressive tumours like UT. A questionnaire was sent to 91 CRs to assess whet…
No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy
Breast cancer (BC) is globally the most frequent cancer in women. Adherence to endocrine therapy (ET) in hormone-receptor-positive BC patients is active and voluntary for the first five years after diagnosis. This study examines the impact of adherence to ET on 10-year excess mortality (EM) in patients diagnosed with Stages I to III BC (N = 2297). Since sample size is an issue for estimating age- and stage-specific survival indicators, we develop…
Predicting Ovarian-Cancer Burden in Catalonia by 2030
Ovarian cancer is the most lethal gynaecological cancer in very-high-human-development-index regions. Ovarian cancer incidence and mortality rates are estimated to globally rise by 2035, although incidence and mortality rates depend on the region and prevalence of the associated risk factors. The aim of this study is to assess changes in incidence and mortality of ovarian cancer in Catalonia by 2030. Bayesian autoregressive age-period-cohort mode…
Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain
Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of d…
Variation of Cancer Incidence between and within GRELL Countries
Variation in cancer incidence between countries and groups of countries has been well studied. However cancer incidence is linked to risk factors that may vary within countries, and may subsist in localized geographic areas. In this study we investigated between- and within-country variation in the incidence of all cancers combined for countries belonging to the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). W…
Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
Studies about the survival of patients with prostate cancer by stage or risk of progression are scarce. The aims of this study were (1) to determine the cause-specific survival by risk in prostate cancer patients in Mallorca diagnosed in the period 2006-2011; (2) to identify the factors that explain and predict the likelihood of survival and the risk of dying from this type of cancer; and (3) to determine the distribution of prostate cancer by ri…
Exceso de mortalidad en las pacientes con cáncer de mama en estadios precoces en Tarragona y Gerona (España)
Analizar la supervivencia poblacional del cáncer de mama (CM) en estadios precoces, estimando la tendencia temporal del exceso de mortalidad (EM) a largo plazo en periodos anuales y quinquenales, y determinando, si es posible, una proporción de pacientes que puedan considerarse curadas. Se incluyó la cohorte de pacientes diagnosticadas de CM en estadios I y II antes de los 60 años de edad en Gerona y Tarragona (N = 2453). Se calcularon la supervi…
Regstattools
Unlike other similar applications, REGSTATTOOLS does not require local software installation and it is simple to use, fast and easy to interpret. It is a set of web-based statistical tools intended for automated calculation of population indicators that any professional in health or social sciences may require
P1-307 Higher cancer detection risk in women with a false positive result in breast cancer screening in Spain
Introduction Breast screening reduces mortality from breast cancer through early detection. Despite its benefits, breast cancer screening presents some adverse effects, as false positive (FP) results. Our aim was to estimate the risk of cancer detection associated to have experienced a previous FP mammography. Methods The Cumulative False Positive Risk study includes eight population-based screening programs in Spain, between 1990 and 2006, that …
P1-308 Effect of false-positives and women's characteristics on the long-term attitude towards breast cancer screening
Introduction Adherence to breast cancer screening is affected by presence of previous false-positives and regular participation in previous invitations. Our aim was to estimate the long-term adherence to breast cancer screening and how false-positive and women9s characteristics affect the probability of re-attending screening. Methods Retrospective Cohort study of women aged 45–69 years invited to participate in any of 10 Spanish breast cancer sc…
Sin obras prominentes en esta página.
P1-307 Higher cancer detection risk in women with a false positive result in breast cancer screening in Spain
Introduction Breast screening reduces mortality from breast cancer through early detection. Despite its benefits, breast cancer screening presents some adverse effects, as false positive (FP) results. Our aim was to estimate the risk of cancer detection associated to have experienced a previous FP mammography. Methods The Cumulative False Positive Risk study includes eight population-based screening programs in Spain, between 1990 and 2006, that …
P1-308 Effect of false-positives and women's characteristics on the long-term attitude towards breast cancer screening
Introduction Adherence to breast cancer screening is affected by presence of previous false-positives and regular participation in previous invitations. Our aim was to estimate the long-term adherence to breast cancer screening and how false-positive and women9s characteristics affect the probability of re-attending screening. Methods Retrospective Cohort study of women aged 45–69 years invited to participate in any of 10 Spanish breast cancer sc…
Regstattools
Unlike other similar applications, REGSTATTOOLS does not require local software installation and it is simple to use, fast and easy to interpret. It is a set of web-based statistical tools intended for automated calculation of population indicators that any professional in health or social sciences may require
Exceso de mortalidad en las pacientes con cáncer de mama en estadios precoces en Tarragona y Gerona (España)
Analizar la supervivencia poblacional del cáncer de mama (CM) en estadios precoces, estimando la tendencia temporal del exceso de mortalidad (EM) a largo plazo en periodos anuales y quinquenales, y determinando, si es posible, una proporción de pacientes que puedan considerarse curadas. Se incluyó la cohorte de pacientes diagnosticadas de CM en estadios I y II antes de los 60 años de edad en Gerona y Tarragona (N = 2453). Se calcularon la supervi…
Variation of Cancer Incidence between and within GRELL Countries
Variation in cancer incidence between countries and groups of countries has been well studied. However cancer incidence is linked to risk factors that may vary within countries, and may subsist in localized geographic areas. In this study we investigated between- and within-country variation in the incidence of all cancers combined for countries belonging to the Group for Cancer Epidemiology and Registration in Latin Language Countries (GRELL). W…
Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
Studies about the survival of patients with prostate cancer by stage or risk of progression are scarce. The aims of this study were (1) to determine the cause-specific survival by risk in prostate cancer patients in Mallorca diagnosed in the period 2006-2011; (2) to identify the factors that explain and predict the likelihood of survival and the risk of dying from this type of cancer; and (3) to determine the distribution of prostate cancer by ri…
Registration of Urothelial Tumours in Cancer Registries
Due to the differences in the definition, criteria of inclusion and coding of urothelial tumours (UTs), data of different cancer registries (CRs) are not comparable. The aim of this work is to study current practices of registration of UT in the European CR of the GRELL countries in order to propose new registration rules to correctly describe incidence and survival of progressive tumours like UT. A questionnaire was sent to 91 CRs to assess whet…
No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy
Breast cancer (BC) is globally the most frequent cancer in women. Adherence to endocrine therapy (ET) in hormone-receptor-positive BC patients is active and voluntary for the first five years after diagnosis. This study examines the impact of adherence to ET on 10-year excess mortality (EM) in patients diagnosed with Stages I to III BC (N = 2297). Since sample size is an issue for estimating age- and stage-specific survival indicators, we develop…
Predicting Ovarian-Cancer Burden in Catalonia by 2030
Ovarian cancer is the most lethal gynaecological cancer in very-high-human-development-index regions. Ovarian cancer incidence and mortality rates are estimated to globally rise by 2035, although incidence and mortality rates depend on the region and prevalence of the associated risk factors. The aim of this study is to assess changes in incidence and mortality of ovarian cancer in Catalonia by 2030. Bayesian autoregressive age-period-cohort mode…
Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain
Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of d…
Mejorando El Programa De Cribado Del Cáncer Colorrectal Con Una Firma Bacteriana en El Protocolo
Estudio Poblacional De La Incidencia Y Supervivencia Del Carcinoma Epidermoide Cutáneo en España
Is Cancer Increasing in Young Adults in Spain? Incidence Trends for the Period 1993-2018
A European collaborative initiative to systematically map cancer risk by migration background
BACKGROUND: The World Health Organization (WHO) Action Plan for Refugee and Migrant Health highlights the need for strengthened migration health governance and data-informed policies. A major barrier in Europe has been the lack of systematically collected and comparable cancer data stratified by migration background. METHODS: This study assesses the availability of routine data to map and examines differences of cancer risk among those with a mig…
Cancer (10 obras) · Medicine (10 obras) · Global Cancer Incidence and Screening (8 obras) · Internal Medicine (7 obras) · Gynecology (6 obras) · Cancer registry (5 obras) · Population (5 obras) · Breast cancer (4 obras) · Cohort (4 obras) · Data-Driven Disease Surveillance (4 obras)